Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

435.62 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Mar 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	435.62
Bid (Size)	435.64 (80)
Ask (Size)	445.00 (40)
Prev. Close	435.62
Today's Range	435.62 - 435.62
52wk Range	265.00 - 615.00
Shares Outstanding	17,103,395
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Madrigal (MDGL) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Madrigal (MDGL) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗

February 23, 2026

Praxis Precision Medicines develops therapies for neurological and psychiatric disorders, aiming to address unmet needs in the CNS market.

Via The Motley Fool

Performance

YTD	-26.6%	-26.6%
1 Month	-11.0%	-11.0%
3 Month	-24.9%	-24.9%
6 Month	-0.1%	-0.1%
1 Year	+39.0%	+39.0%

More News

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗

February 23, 2026

Via The Motley Fool

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Reports Q4 2025 Revenue Beat and Significant EPS Miss ↗

February 19, 2026

Via Chartmill

Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China’s Ribo ↗

February 11, 2026

Via Stocktwits

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗

February 17, 2026

Via The Motley Fool

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗

February 17, 2026

Via The Motley Fool

Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗

February 17, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Why Madrigal Pharmaceuticals Stock Slumped on Tuesday ↗

January 06, 2026

Via The Motley Fool

Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead ↗

January 05, 2026

Via The Motley Fool

2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 ↗

January 03, 2026

Via The Motley Fool

2 Predictions for Novo Nordisk in 2026 ↗

December 14, 2025

Via The Motley Fool

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run ↗

December 09, 2025

Via The Motley Fool

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

December 03, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 28, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 27, 2025

Via The Motley Fool

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

November 27, 2025

Via The Motley Fool

Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗

November 27, 2025

Via The Motley Fool

Madrigal Pharma Stock Sees Buyout Hype – Retail Predicts ‘Huge’ Deal On Liver Disease Drug Momentum ↗

November 24, 2025

Via Stocktwits

Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday ↗

November 20, 2025

Via Benzinga

Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? ↗

November 09, 2025

Via Benzinga

Madrigal Pharmaceuticals (NASDAQ:MDGL) Q3 2025 Earnings: Revenue Beat and EPS Miss Drive Pre-Market Surge ↗

November 04, 2025

Via Chartmill

A Look Ahead: Madrigal Pharmaceuticals's Earnings Forecast ↗

November 03, 2025

Via Benzinga

Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?

Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market

What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?

The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 435.62

When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 03/02/26 04:00 PM ET

What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 7.45B

How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?

Madrigal Pharmaceuticals, Inc. - Common Stock has 7B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.